GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Globus Medical Inc (MEX:GMED) » Definitions » Cyclically Adjusted FCF per Share

Globus Medical (MEX:GMED) Cyclically Adjusted FCF per Share : MXN25.29 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Globus Medical Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Globus Medical's adjusted free cash flow per share for the three months ended in Mar. 2024 was MXN2.920. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN25.29 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Globus Medical's average Cyclically Adjusted FCF Growth Rate was 3.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Globus Medical was 11.90% per year. The lowest was 11.90% per year. And the median was 11.90% per year.

As of today (2024-06-21), Globus Medical's current stock price is MXN990.00. Globus Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was MXN25.29. Globus Medical's Cyclically Adjusted Price-to-FCF of today is 39.15.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Globus Medical was 77.49. The lowest was 32.96. And the median was 54.05.


Globus Medical Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Globus Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Globus Medical Cyclically Adjusted FCF per Share Chart

Globus Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 16.32 26.25 23.94 25.27

Globus Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.63 21.88 26.23 25.27 25.29

Competitive Comparison of Globus Medical's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Globus Medical's Cyclically Adjusted Price-to-FCF falls into.



Globus Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Globus Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.92/131.7762*131.7762
=2.920

Current CPI (Mar. 2024) = 131.7762.

Globus Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.853 100.560 1.118
201409 4.531 100.428 5.945
201412 -1.102 99.070 -1.466
201503 4.362 99.621 5.770
201506 -0.774 100.684 -1.013
201509 3.264 100.392 4.284
201512 5.715 99.792 7.547
201603 8.257 100.470 10.830
201606 2.396 101.688 3.105
201609 7.233 101.861 9.357
201612 2.592 101.863 3.353
201703 8.124 102.862 10.408
201706 2.300 103.349 2.933
201709 4.076 104.136 5.158
201712 6.249 104.011 7.917
201803 7.217 105.290 9.033
201806 3.576 106.317 4.432
201809 6.691 106.507 8.278
201812 5.252 105.998 6.529
201903 2.114 107.251 2.597
201906 1.486 108.070 1.812
201909 8.470 108.329 10.303
201912 7.057 108.420 8.577
202003 4.586 108.902 5.549
202006 3.104 108.767 3.761
202009 7.897 109.815 9.476
202012 12.969 109.897 15.551
202103 9.959 111.754 11.743
202106 9.773 114.631 11.235
202109 11.710 115.734 13.333
202112 11.656 117.630 13.058
202203 4.729 121.301 5.137
202206 2.567 125.017 2.706
202209 4.153 125.227 4.370
202212 8.705 125.222 9.161
202303 6.583 127.348 6.812
202306 2.890 128.729 2.958
202309 4.376 129.860 4.441
202312 10.056 129.419 10.239
202403 2.920 131.776 2.920

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Globus Medical  (MEX:GMED) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Globus Medical's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=990.00/25.29
=39.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Globus Medical was 77.49. The lowest was 32.96. And the median was 54.05.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Globus Medical Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Globus Medical's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Globus Medical (MEX:GMED) Business Description

Traded in Other Exchanges
Address
2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.